Safety profile of Tiotropium + Olodaterol used as maintenance treatment in COPD patients in Taiwan: a non-interventional study based on the Taiwan National Health Insurance (NHI) data (1237-0109)

First published 17/05/2022

Last updated 04/06/2024

EU PAS number:

EUPAS47368

Study

Finalised

Documents

Study protocol

Initial protocol

1237-0109_clinical trial protocol_version01_2022-05-11.pdf

English (439.46 KB - PDF)View document

Study results

Study report

1237-0109 final CTR 20230609.pdf

English (262.39 KB - PDF)View document

Other information

Secondary tabs